Peptidomimetic protease inhibitors

Details for Australian Patent Application No. 2007240156 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Tebbe, Mark Joseph; Glass, John Irvin; Parker III, Raymond Samuel; Victor, Frantz; Garcia-Paredes, Cristina; Snyder, Nancy June; Collado, Ivan; Lamar, Jason Eric; Yip, Yvonne Yee Mai; Wang, Q. May; Sun, Xicheng David; Jin, Ling; Chen, Shu Hui; Babine, Robert Edward; Guo, Deqi

Agent Spruson & Ferguson

Pub. Number AU-B-2007240156

Parent 2001288318

Filing date 6 December 2007

Wipo publication date 3 January 2008

Acceptance publication date 1 December 2011

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/437 (2006.01)

A61K 31/7052 (2006.01)

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/023 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/027 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/03 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/02 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12N 7/06 (2006.01) Viruses, e.g. bacteriophages

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

Event Publications

20 December 2007 Complete Application Filed

3 January 2008 Application Open to Public Inspection

  Published as AU-B-2007240156

1 December 2011 Application Accepted

  Published as AU-B-2007240156

29 March 2012 Standard Patent Sealed

11 October 2012 Extension of Term of Standard Patents

  Vertex Pharmaceuticals Incorporated The earliest first regulatory approval date provided by the patentee 06 Mar 2012 For the goods INCIVO telaprevir

25 October 2012 Extension of Term of Standard Patents

  Vertex Pharmaceuticals Incorporated The earliest first regulatory approval date provided by the patentee 06 Mar 2012 For the goods INCIVO telaprevir Address for service in Australia: Shelston IP 60 Margaret Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007240157-Systems and methods for endoscope integrity testing

2007240155-Lotto game